Search

Search Constraints

You searched for: Author/Creator Chan, E.

Search Results

2. 500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028. Issue 3 (September 2015)

4. ACALABRUTINIB PLUS PEMBROLIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 1/2 STUDY. (12th June 2019)

6. Consensus communication on early peanut introduction and the prevention of peanut allergy in high‐risk infants. Issue 10 (October 2015)

8. DIGITAL SPATIAL PROFILING OF IMMUNE MARKERS IN R‐CHOP TREATED DIFFUSE LARGE B‐CELL LYMPHOMA REVEALS A DOMINANT PROGNOSTIC SIGNIFICANCE OF M2 MACROPHAGE INFILTRATION. (12th June 2019)